Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series

Journal of Neuro-oncology
Marc C Chamberlain, Bryan T Kim

Abstract

A single institution retrospective evaluation of nivolumab following disease progression on bevacizumab in adults with recurrent glioblastoma (GBM) with an objective of determining progression free survival (PFS). There is no accepted therapy for recurrent GBM after failure of bevacizumab. 16 adults, ages 52-72 years (median 62), with recurrent GBM were treated. All patients had previously been treated with surgery, concurrent radiotherapy and temozolomide, and post-radiotherapy temozolomide. Bevacizumab (with or without lomustine) was administered to all patients at first recurrence. Patients were treated with nivolumab only (3 mg/kg) once every 2 weeks at second recurrence. One cycle of nivolumab was defined as 2 treatments. Neurological evaluation was performed bi-weekly and neuroradiographic assessment every 4 weeks. A total of 37 treatment cycles (median 2) were administered of nivolumab in which there were 14 Grade 2 adverse events (AEs) and Grade 3 AEs in two patients. No Grade 4 or 5 AEs were seen. Following 1 month of nivolumab, seven patients demonstrated progressive disease and discontinued therapy. No patient demonstrated a response though nine patients demonstrated neuroradiographic stable response. Survival in the...Continue Reading

References

Nov 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephanie E CombsDaniela Schulz-Ertner
Oct 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James J VredenburghHenry S Friedman
Dec 31, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Teri N KreislHoward A Fine
Jul 14, 2009·Journal of Neuro-oncology·Marc C Chamberlain, Sandra K Johnston
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henry S FriedmanTimothy Cloughesy
Oct 20, 2009·Journal of Neuro-oncology·Roy G TorcuatorTom Mikkelsen
Feb 4, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wolfgang WickHoward A Fine
Mar 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick Y WenSusan M Chang
Mar 24, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James R PerryJean-François Pouliot
May 19, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shannon E FoghMaria Werner-Wasik
Jul 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John K ParkPeter McL Black
Aug 19, 2010·Neuro-oncology·Sith SathornsumeteeDavid A Reardon
Jun 1, 2011·Journal of Neuro-oncology·Marc C Chamberlain, Sandra K Johnston
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
May 23, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Roger StuppPhilip H Gutin
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Nov 9, 2012·Neuro-oncology·Michael WellerWolfgang Wick
Aug 14, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tracy T BatchelorMartin van den Bent
Mar 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suzanne L TopalianF Stephen Hodi
Mar 8, 2014·Oncoimmunology·Stéphane ChampiatJean Charles Soria
Mar 29, 2014·Neuro-oncology·Seunggu J HanNicholas A Butowski
Apr 18, 2014·Journal of Neuro-oncology·Marc C ChamberlainUNKNOWN Brain Tumor Investigational Consortium (BTIC)
Jul 27, 2014·Neuro-oncology·Martin J van den Bent, Walter Taal
Sep 6, 2014·Neuro-oncology·David A ReardonGlenn Dranoff
Oct 24, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wolfgang WickStephanie E Combs
Feb 7, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael WellerUNKNOWN DIRECTOR Study Group
Mar 25, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David F McDermottMichael B Atkins
Apr 22, 2015·The New England Journal of Medicine·Edward B GaronUNKNOWN KEYNOTE-001 Investigators
Jun 2, 2015·The New England Journal of Medicine·Dung T LeLuis A Diaz
Jul 2, 2015·Neuro-oncology·Kathryn M FieldMark A Rosenthal
Aug 12, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Victoria L Chiou, Mauricio Burotto
Sep 10, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Junzo HamanishiIkuo Konishi
Sep 29, 2015·The New England Journal of Medicine·Hossein BorghaeiJulie R Brahmer
Nov 13, 2015·Future Oncology·Evidio Domingo-Musibay, Evanthia Galanis
Mar 24, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric BouffetUri Tabori
Apr 14, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Margaretha G M RoemerMargaret A Shipp
Jun 9, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexander M LesokhinJohn Timmerman

❮ Previous
Next ❯

Citations

Mar 10, 2018·Journal of Neuro-oncology·A ZemlinD Steinmann
Jul 11, 2019·Targeted Oncology·Kunal DesaiManmeet Ahluwalia
Apr 10, 2020·Future Oncology·Vincenzo Di NunnoAlba Ariela Brandes
Sep 5, 2020·The Journal of International Medical Research·Can ChenYanling Zhang
May 21, 2018·Journal of Neuro-oncology·Megan ManticaJan Drappatz
Jan 11, 2018·Scientific Reports·Hiroshi NakashimaE Antonio Chiocca
Oct 14, 2020·Cell Biology International·S Daisy PrecillaAnitha Thirugnanasambandhar Sivasubramanian
Jan 25, 2021·Advanced Drug Delivery Reviews·Taskeen Iqbal JanjuaAmirali Popat
Nov 13, 2020·Frontiers in Immunology·Joshua R D PearsonStephanie E B McArdle
Jan 9, 2019·Trends in Cancer·Luiz Henrique Medeiros GeraldoFlavia Regina Souza Lima
Jul 21, 2021·Journal for Immunotherapy of Cancer·Montserrat PuigdellosesMarta Alonso
Oct 16, 2021·Frontiers in Cell and Developmental Biology·Chunyu ZhangDaofeng Tian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.